One possible explanation for why it is difficult to detect an effect of TP53 codon 72 polymorphism on ovarian cancer based on these epidemiological results is that there was loss of heterozygosity (LOH) at the TP53 locus. This evidence concerns the gene TP53 and ovarian carcinoma.